Philips Verida Sets New Benchmark for AI Spectral CT

For high-demand applications such as cardiology, oncology, emergency care and routine diagnostic imaging, Philips has introduced Verida, the world’s first detector-based spectral CT system fully powered by artificial intelligence. By integrating AI across the entire imaging chain, Verida is designed to deliver higher image quality, lower radiation dose and faster clinical throughput than competing CT technologies.

AI Across the Full Imaging Chain
Verida optimizes every step of the CT process, from data acquisition to reconstruction. By combining AI with Philips’ established detector-based spectral CT, the system reduces image noise while enhancing both spectral and conventional image clarity. AI-driven processing enables significant radiation dose reduction without degrading diagnostic quality, while also cutting energy consumption by up to 45 percent.

Unlike post-processed spectral CT solutions, Philips’ detector-based approach captures spectral data directly at the detector level. This allows multiple spectral results to be generated from a single scan with no tradeoffs in scan time or performance. With more than 800 global installations and over 800 peer-reviewed publications supporting its clinical use, Philips’ spectral CT is already deeply embedded in hospital workflows.

Throughput and Workflow Efficiency
Verida reconstructs up to 145 images per second, allowing full exams to appear in under 30 seconds. This represents a twofold acceleration compared to previous systems and supports daily volumes of up to 270 patient exams. The platform builds on Philips’ Spectral Precise Image technology, which combines deep-learning reconstruction with advanced spectral imaging, along with the third-generation Nano-panel Precise dual-layer detector engineered for intrinsic noise reduction and AI optimization.

This performance enables clinicians to access rich spectral information from a single scan, minimizing repeat imaging and accelerating diagnostic decisions in time-critical environments.

Differentiation from Photon-Counting CT
While photon-counting CT remains largely confined to research environments and introduces new system complexity, Philips’ detector-based spectral CT has been established in routine clinical use for more than a decade. Verida delivers comparable or superior diagnostic outcomes with higher operational reliability, stronger throughput performance and significantly lower total cost of ownership.

This positions Verida as a practical alternative to photon-counting systems for hospitals seeking immediate clinical and operational impact without workflow disruption.

Operational and Clinical Impact
Verida extends Philips’ software-defined CT strategy by combining AI-driven spectral precision with workflow automation. The system is engineered to reduce repeat scans, standardize image quality, and support consistent diagnostics across all care pathways. By improving characterization of tissues that appear identical on conventional CT, Verida strengthens diagnostic confidence while increasing department productivity.

Philips officially unveiled Verida at RSNA 2025 — held November 30 to December 4, 2025 — positioning the system as a flagship platform for next-generation spectral CT in clinical practice.

www.philips.com